Methods and compositions for treating conditions associated with angiogenesis using a vascular adhesion protein-1 (vap-1) inhibitor
AssigneeMassachusetts Eye and Ear Infirmary
InventorAli Hafezi-Moghadam
Life of this patent
Estimating the term…
Abstract
The invention relates generally to methods and compositions for treating conditions associated with angiogenesis, and, more specifically, the invention relates to methods and compositions for treating conditions associated with angiogenesis using vascular adhesion protein-1 (VAP-1) inhibitors. The invention also relates to methods and compositions for treating conditions associated with lymphangiogenesis using VAP-1 inhibitors.
Claims22
A method for treating an angiogenic condition, the method comprising:
- administering a VAP-1 inhibitor to a subject in an amount sufficient to inhibit angiogenesis.
7-8. (canceled)
A method for treating an ocular angiogenic condition, the method comprising:
- administering a VAP-1 inhibitor to a subject in an amount sufficient to inhibit angiogenesis of the eye.
A method for treating a lymphangiogenic condition, the method comprising:
- administering a VAP-1 inhibitor to a subject in an amount sufficient to inhibit lymphangiogenesis.
21-23. (canceled)
Dependencies are inferred from the claim text.